US equities |
NVDA $239.24 ▲+0.14% MU $1,045.56 ▼-1.73% SPCX $171.92 ▲+0.49% AMD $649.42 ▲+2.80% MRVL $287.01 ▲+5.81% AVGO $375.81 ▲+3.67% INTC $112.50 ▼-3.18% MSFT $529.30 ▲+0.78%
FinancialContent

Articles published by Pluristyx

News headline image
Pluristyx Completes Investment Round to Expand Product Portfolio and Commercial Operations
From Pluristyx
Via Business Wire
News headline image
Pluristyx Launches PluriForm™ Organoid Kit, Slashing Weeks Off Organoid Development Timelines
From Pluristyx
Via Business Wire
News headline image
Pluristyx Enables Safer, Universal Cell Therapy Solutions with Newly Issued U.S. Patent for iACT Stealth™ Technology
From Pluristyx
Via Business Wire
News headline image
Pluristyx Announces Filing of Drug Master File for PluriBank™ iPSC Lines with U.S. FDA
From Pluristyx
Via Business Wire
News headline image
Pluristyx Announces Immediate Availability of GMP-Compliant PSXi013 iPSC Line for Advanced Therapy Development
From Pluristyx
Via Business Wire
News headline image
Pluristyx Announces License Agreement with Humacyte to Develop BioVascular Pancreas using iPSCs
From Pluristyx
Via Business Wire
Tickers HUMA
News headline image
Pluristyx Announces Major New Funding Round to Bolster Expansion Plans
From Pluristyx
Via Business Wire
News headline image
Pluristyx/panCELLa Become Industry Resource Partner with the California Institute for Regenerative Medicine
From Pluristyx
Via Business Wire
News headline image
Pluristyx and panCELLa Expand Intellectual Property Portfolio for Pluripotent Stem Cell Cloaking Technology
From Pluristyx
Via Business Wire
News headline image
Pluristyx, panCELLa, and Implant Therapeutics Announce Definitive Merger Agreement
From Pluristyx
Via Business Wire